- Sunday, December 7, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Regenerative Medicine Market by Technology
- December 30, 2019
- ID: SR/HC-01
- Format:Pdf
- Pages:220
Global Regenerative Medicine Market by Technology (Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics), By Source (Autologous and Allogenic), By Application (Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others), By End-Users(Hospitals, Ambulatory surgery centers (ASCs), Clinics and Others), and By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
Global Regenerative Medicine Market Overview
Global Regenerative Medicine Market is estimated to reach USD 86.8 billion by 2030, with a growth of a CAGR of 16.14% during the estimated period 2022-2030. It was valued at USD 25.6 billion in 2022. Regenerative medicine refers to the use of biological and engineering theoretical methods to create lost or functionally damaged tissues and organs. Regenerative medicine can be described as the theory, technology, and surgical operations of tissue regeneration in the body. It can also consider as a discipline that studies how to promote the physiological repair of trauma and tissue and organ defects and how to perform tissue and organ regeneration and functional reconstruction. Regenerative medicine marks a new era for the medicine to rebuild, regenerate, manufacture, and replace tissues and organs. It also brings new hope for most medical problems facing humans, such as cardiovascular disease, autoimmune diseases, diabetes, Malignant tumors, Alzheimer’s disease, Parkinson’s disease, congenital genetic defects, and other diseases and the treatment of various tissue and organ damage.Global Regenerative Medicine Market Insights
The rise in the prevalence of chronic diseases & trauma emergencies and the emergence of stem cell technology is likely to boom the global regenerative medicine market in the forecast period. Additionally, conditions related to aging has become a significant medical and social problem across the globe, which leads to the growth of the global regenerative medicine market. Moreover, the rise in the number of patients with cardiovascular disease, diabetes, and millions of patients with Alzheimer’s disease and hematological tumors will accelerate the global regenerative medicine market. Furthermore, accelerating the development of the regenerative medicine market is of great and practical significance for improving human living standards and benefiting human health. Further, the surge in funding for regenerative medicine research, and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds are vital factors projected to trigger the global regenerative medicine market.Growth Driver
The rise in diseases related to aging and chronic diseases
The increase in diseases related to aging has become a significant medical and social problem. At present, one of the primary causes among the elderly population is cell aging, which leads to issues such as cell damage, the development of inflammatory processes, slow regeneration, and reduced functional activity of corresponding tissues and organs. According to WHO, the proportion of the burden of non-communicable diseases anticipated to increase to 57% by 2020. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity, and diabetes. It has projected that, by 2020, chronic diseases will account for almost three-quarter of all deaths worldwide, and that 71% of deaths due to ischaemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries.Rising Government Investments in Regenerative Medicine
Governments and people in various countries have actively invested considerable resources in recent years to develop regenerative medicine. In the Asia Pacific, Japan is the first country to propose specific legislation of the global regenerative medicine. Clinical trials would also begin in areas such as the retina, the esophagus, heart, etc. World Health Organization (WHO) launched an initiative to eliminate hepatitis by 2030.Resolving past incurable diseases with the help of human tissue or organ regeneration
Regenerative medicine aimed at repairing, replacing, and rejuvenating tissues or organs to improve human life caused by trauma, disease, or natural aging. It combines different specialties across fields, including biology, chemistry, computer science, genetics, robotics, etc., not only to activate the body’s original natural repair mechanism, but also to make it doubly useful. According to the World Bank, the population aged 65 and above increased from 7.64% in 2010 to 8.92% of the overall population in 2018.Technology Segmental Analysis
Based on technology, the global Regenerative Medicine Market categorized into Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics. The Cellular Therapy segment projected to lead the market and witnessed, owing to its efficiency in restoring the lost function of tissues and organs. Cellular Therapy can solve the problem of organ transplantation, and organ transplantation can become one of the means of cancer treatment. The gene therapy segment will drive by its application to reduce levels of the disease-causing version of a protein and increase the production of disease-fighting proteins.Source Segmental Analysis
Based on the Source, the Global Regenerative Medicine Market bifurcated into Autologous and Allogenic. The Autologous segment estimated to exhibit 61.14% market share in 2018 and anticipated to dominate the market due to their features such as cells derived from patients themselves. The use of autologous is a safe therapeutic option as the cells will not elicit an immune response. Allogenic will grow by its properties, such as the stem cells are from a donor. Allogenic do not elicit robust immune responses.Application Segmental Analysis
Based on the application, the Global Regenerative Medicine Market segmented into Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others. The oncology segment witnessed to dominate the market due to the surge in the cancer-affected population along with huge investments done in research related to cancer and development of regenerative & advanced cell therapies by the various government in developing and developed countries. The dermatology segment will driven by the presence of easy grafting techniques for dermatological wounds and diseases related to skin.End-User Segmental Analysis
By the End-user, the Global Regenerative Medicine market segregated into Hospitals, Ambulatory surgery centers (ASCs), Clinics, and Others. The Hospital segment generated the highest revenue and anticipated to dominate the market over the forecast period due to the partnership formed between hospitals and regenerative medicine manufacturing companies to provide cell therapy and tissue scaffolds to improve patient care and treatment. The clinics’ segment will grow on account of certified clinics that offer healthcare services to people. These centers have specialized departments for regenerative medicine, which provide care and treatment.Region Segmental Analysis
Based on geography, the global Regenerative Medicine market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America attributed to generating highest market share in 2021 and estimated to generate USD 66.57 Billion revenue by 2030 owing to the availability of advanced technologies and the presence of research institutes and the rising initiatives by government and private organizations. Europe will be the fastest-growing region during the forecast period. It has generated revenue of 74.32 (Approximately) USD Billion in 2022 on account of the enormous growing aging population along with rising medical needs of the people and changing lifestyle.Competitor Analysis
Companies such as Integra LifeSciences Corporation, MiMedx Group, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Medtronic Plc., Athersys Inc., US Stem Cell, Organogenesis Inc., Acelity Holdings Inc., Isto Biologics, Cryolife Inc. and Baxter are the key players in the Global Regenerative Medicine Market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Regenerative Medicine Service Providers
- Research organizations and consulting companies
- Organizations, associations, and alliances related to Regenerative Medicine
- Regulatory bodies
Scope of the report
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 64.6 Billion |
| Revenue forecast in 2027 | USD 190.08 Billion |
| Growth Rate | CAGR of 19.14% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | Integra LifeSciences Corporation, Pfizer Inc., MiMedx Group, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Acelity Holdings Inc., Isto Biologics, Cryolife Inc., Medtronic Plc., Athersys Inc., US Stem Cell, Organogenesis Inc., and Baxter. |
Recent Developments
- In September 2021, a rare autologous bone marrow cell transplant was done for the first time at Raj Hospital, Ranchi, Jharkhand.
- In September 2021, the first-ever Genome sequencing lab opened in Tamil Nadu to detect SARS-CoV-2 virus variants.
- In September 2021, QC Kinetix launched a state-of-the-art regenerative medicine clinic in Fort Worth, Dallas, TX.
The objective of the Research
- Market Modelling Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product Analysis Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis This analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis Segmental analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- Geographical Mapping The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Technology- Cellular Therapy
- Gene Therapy
- Tissue Engineering
- Exosome Therapeutics
- Autologous
- Allogenic
- Dermatology
- Musculoskeletal
- Oncology
- Cardiovascular
- Neurology
- Hematology & Immunology
- Others
- Hospitals
- Ambulatory surgery centers (ASCs)
- Clinics
- Others
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Patient Temperature Monitoring Market
India Automotive Sensors Market
Conductive Silver Paste Market
Automated Material Handling Market Data
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Regenerative Medicine Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Technology
5.2.1.1. Cellular Therapy
5.2.1.2. Gene Therapy
5.2.1.3. Tissue Engineering
5.2.1.4. Exosome Therapeutics
5.2.2. By Source
5.2.2.1. Autologous
5.2.2.2. Allogenic
5.2.3. By Application
5.2.3.1. Dermatology
5.2.3.2. Musculoskeletal
5.2.3.3. Oncology
5.2.3.4. Cardiovascular
5.2.3.5. Neurology
5.2.3.6. Hematology & Immunology
5.2.3.7. Others
5.2.4. By End-Users
5.2.4.1. Hospitals
5.2.4.2. Ambulatory surgery centers (ASCs)
5.2.4.3. Clinics
5.2.4.4. Others
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia-Pacific
5.2.5.4. South America
5.2.5.5. The Middle East & Africa
- North America Regenerative Medicine Market Overview
6.1. North America Regenerative Medicine Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Technology
6.2.1.1. Cellular Therapy
6.2.1.2. Gene Therapy
6.2.1.3. Tissue Engineering
6.2.1.4. Exosome Therapeutics
6.2.2. By Source
6.2.2.1. Autologous
6.2.2.2. Allogenic
6.2.3. By Application
6.2.3.1. Dermatology
6.2.3.2. Musculoskeletal
6.2.3.3. Oncology
6.2.3.4. Cardiovascular
6.2.3.5. Neurology
6.2.3.6. Hematology & Immunology
6.2.3.7. Others
6.2.4. By End-Users
6.2.4.1. Hospitals
6.2.4.2. Ambulatory surgery centers (ASCs)
6.2.4.3. Clinics
6.2.4.4. Others
6.2.5. By Country
6.2.5.1. US
6.2.5.2. Canada
6.2.5.3. Mexico
6.2.6. Company Market Share (Top 3-5)
6.2.7. Economic Impact Study on North America Regenerative Medicine Market
- Europe Regenerative Medicine Market Overview
7.1. Europe Regenerative Medicine Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Technology
7.2.1.1. Cellular Therapy
7.2.1.2. Gene Therapy
7.2.1.3. Tissue Engineering
7.2.1.4. Exosome Therapeutics
7.2.2. By Source
7.2.2.1. Autologous
7.2.2.2. Allogenic
7.2.3. By Application
7.2.3.1. Dermatology
7.2.3.2. Musculoskeletal
7.2.3.3. Oncology
7.2.3.4. Cardiovascular
7.2.3.5. Neurology
7.2.3.6. Hematology & Immunology
7.2.3.7. Others
7.2.4. By End-Users
7.2.4.1. Hospitals
7.2.4.2. Ambulatory surgery centers (ASCs)
7.2.4.3. Clinics
7.2.4.4. Others
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. UK
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Rest of Europe
7.2.6. Company Market Share (Top 3-5)
7.2.7. Economic Impact Study on Europe Regenerative Medicine Market
- Asia-Pacific Regenerative Medicine Market Overview
8.1. Asia-Pacific Regenerative Medicine Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Technology
8.2.1.1. Cellular Therapy
8.2.1.2. Gene Therapy
8.2.1.3. Tissue Engineering
8.2.1.4. Exosome Therapeutics
8.2.2. By Source
8.2.2.1. Autologous
8.2.2.2. Allogenic
8.2.3. By Application
8.2.3.1. Dermatology
8.2.3.2. Musculoskeletal
8.2.3.3. Oncology
8.2.3.4. Cardiovascular
8.2.3.5. Neurology
8.2.3.6. Hematology & Immunology
8.2.3.7. Others
8.2.4. By End-Users
8.2.4.1. Hospitals
8.2.4.2. Ambulatory surgery centers (ASCs)
8.2.4.3. Clinics
8.2.4.4. Others
8.2.5. By Country
8.2.5.1. India
8.2.5.2. Japan
8.2.5.3. Australia
8.2.5.4. Rest of Asia Pacific
8.2.6. Company Market Share (Top 3-5)
8.2.7. Economic Impact Study on Asia Pacific Regenerative Medicine Market
- South America Regenerative Medicine Market Overview
9.1. South America Regenerative Medicine Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Technology
9.2.1.1. Cellular Therapy
9.2.1.2. Gene Therapy
9.2.1.3. Tissue Engineering
9.2.1.4. Exosome Therapeutics
9.2.2. By Source
9.2.2.1. Autologous
9.2.2.2. Allogenic
9.2.3. By Application
9.2.3.1. Dermatology
9.2.3.2. Musculoskeletal
9.2.3.3. Oncology
9.2.3.4. Cardiovascular
9.2.3.5. Neurology
9.2.3.6. Hematology & Immunology
9.2.3.7. Others
9.2.4. By End-Users
9.2.4.1. Hospitals
9.2.4.2. Ambulatory surgery centers (ASCs)
9.2.4.3. Clinics
9.2.4.4. Others
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Argentina
9.2.5.3. Rest of South America
9.2.6. Company Market Share (Top 3-5)
9.2.7. Economic Impact Study on South America Regenerative Medicine Market
- The Middle East & Africa Regenerative Medicine Market Overview
10.1. The Middle East & Africa Regenerative Medicine Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Technology
10.2.1.1. Cellular Therapy
10.2.1.2. Gene Therapy
10.2.1.3. Tissue Engineering
10.2.1.4. Exosome Therapeutics
10.2.2. By Source
10.2.2.1. Autologous
10.2.2.2. Allogenic
10.2.3. By Application
10.2.3.1. Dermatology
10.2.3.2. Musculoskeletal
10.2.3.3. Oncology
10.2.3.4. Cardiovascular
10.2.3.5. Neurology
10.2.3.6. Hematology & Immunology
10.2.3.7. Others
10.2.4. By End-Users
10.2.4.1. Hospitals
10.2.4.2. Ambulatory surgery centers (ASCs)
10.2.4.3. Clinics
10.2.4.4. Others
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. South Africa
10.2.5.4. Rest of the Middle East & Africa
10.2.6. Company Market Share (Top 3-5)
10.2.7. Economic Impact Study on Middle East & Africa Regenerative Medicine Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Integra LifeSciences Corporation
11.7.2. MiMedx Group, Inc.
11.7.3. AstraZeneca
11.7.4. Hoffmann-La Roche Ltd
11.7.5. Merck & Co., Inc.
11.7.6. Pfizer Inc.
11.7.7. Stryker Corporation
11.7.8. Zimmer Biomet Holdings Inc.
11.7.9. Medtronic Plc.
11.7.10. Athersys Inc.
11.7.11. US Stem Cell
11.7.12. Organogenesis Inc.
11.7.13. Acelity Holdings Inc.
11.7.14. Isto Biologics
11.7.15. Cryolife Inc.
11.7.16. Baxter
11.7.17. Other Prominent Players
Frequently Asked Questions (FAQ):
Regenerative medicine refers to biological and theoretical engineering methods to create lost or functionally damaged tissues and organs.
Global Regenerative Medicine Market is estimated to reach USD 86.8 billion by 2030, with a growth of a CAGR of 16.14% during the estimated period 2022-2030. It was valued at USD 25.6 billion in 2022.
Cell therapies, tissue engineering and immunomodulation therapy, are examples of regenerative medicine.
Rising Government investments, Resolving past incurable diseases by human tissue or organ regeneration and increasing illnesses related to aging and chronic diseases are the growth drivers of the global regenerative medicine market.
